Chapter 466 Speech at a surgical conference(1/2)
World Congress of Surgery, San Francisco Plenary Meeting.
Chen Qi, wearing a suit and tie, stood on the highest stage of surgery, facing more than a thousand top surgical experts from various countries, and began his 10-minute special speech.
"Hello everyone, I am Dr. Chen Qi from China. I am very honored. Today, on behalf of our research group, I will introduce to you our latest research results. The topic of my speech today is "New Ideas for Genetic Testing in the Diagnosis of Surgical Diseases"
》.
This is the paper "Genetic Testing in the Diagnosis of Childhood Lung Cancer" that we published in the New England Journal. I believe many doctors have seen it. Today I will introduce this case in detail..."
The venue was unusually quiet. Apart from the chatter of slide exchanges, there was only the sound of rustling notes.
This is not the first time Chen Qi has stood on this stage, so he doesn’t feel much nervous.
On the contrary, the most nervous person is Yuuto Takada, the president of Japan's Sysmex Genetic Testing Company. For him, whether his company will be popular or popular in the future depends entirely on Chen Qi.
"So, when we suspected the source of neonatal lung cancer, we thought of using genetic testing to confirm whether our guess was correct. Finally, after comparison, we found the most advanced genetic testing company in the world, Japan's
Sammikang.
Sysmex is very efficient. It only took 3 days to quickly complete the sequencing of the newborn's lung cancer gene. This bought our research team valuable time. Please see, this is what was done at that time.
Genetic test report.
Finally, we found a malignant tumor on the mother's cervix. Likewise, we continued to cooperate with Sysmex. Their efficiency was as high as ever, and it only took less than 5 days to complete.
Genetic sequencing of maternal cancer cells.
Then Shasemex Company compared the two genes and finally confirmed that the gene overlap rate reached 99.9%. Then we can finally confirm that the source of the newborn's cancer cells is his mother. Please look at the picture, these are two
Gene sequencing and comparison results.
This is also the first case in the world where cancer cells are discovered to be directly transmitted from mother to child. It will also rewrite textbooks and is of great significance. But as doctors, we are not only thinking about this case, but are there other cancer cells that are possible?
Is there the possibility of direct transmission of infection?
So we carried out follow-up research, such as..."
Chen Qi was talking eloquently, and Takada Yuto in the audience was extremely excited.
Because Chen Qi not only mentioned the name of Sysmex many times, but also clearly stated that Sysmex is the most advanced and efficient genetic testing company in the world. This was said in front of more than 1,000 top surgeons.
This advertisement was so good that it almost made Yuto Takada want to hug Chen Qi and kiss him twice, thinking:
"This Chen Sang is indeed an honest person, and he can do good things with money. It seems that the two parties will have more cooperation in the future, and the sponsorship fee will have to be increased."
Below the venue, Professor Zeng touched Professor Wu Mengchao and said with a smile:
"Look at this kid, such an outstanding talent is actually sent to aid Africa. I don't know what Haidong thinks."
Professor Wu also chuckled:
"You can't make a good thing if it's not polished. Chen Qi is still young. It is estimated that Haidong also wanted to focus on cultivating him before letting him go to aid Africa. He will have a good resume in the future, and he will have enough confidence when it comes to promotion. He will not suffer because of his age."
to question.”
Professor Bi on the side touched his chin and said thoughtfully:
"What's so weird about this paper? He mentioned many times how good the Japanese Sysmex genetic testing company is. It seems like this guy must have been paid."
Leader Liu Chumin lowered his head and said softly:
"Sysmex gave their research team US$500,000, which has been prepared by the ministry. Of course Chen Qi has to put in a good word."
"$500,000? Oh my god!"
"Is this guy the God of Wealth? He helped his wife get 2 million U.S. dollars, and he got another 500,000 U.S. dollars on his own. Poor old guys like us wanted to apply for a project, but the hospital just gave us tens of thousands of RMB.
”
"Yeah, it's so irritating that people are so different from each other. I think I will follow Xiao Chen in the future and let him be the boss."
A group of young old men began to drink lemons, and Professor Wu said impatiently:
"Okay, okay, it's up to others whether Xiao Chen is capable. If you are capable, go and get sponsors yourself. So we still need to pay more attention to academic research and hold less inexplicable meetings. Don't let the young man compete with you."
."
Compared with the gossip of Chinese doctors, doctors from other countries are much more serious.
In addition to taking notes, questions also appeared in my mind, and I urgently needed to ask questions after the meeting, um, or rather, question...
After 10 minutes, the timer on the scene made a sound of "all~~~".
Chen Qi also closed his document, "Thank you everyone for listening carefully. My speech has come to an end. Thank you everyone."
Then he bowed slightly to everyone in the audience
Afterwards, there was a burst of warm applause in the venue.
As compatriots, all Chinese doctors stood up and applauded desperately to support this young fellow.
At this time, the host at the meeting picked up the microphone,
"It seems that everyone is more interested in genetic testing technology. Because time is limited, everyone can ask questions, but only one question."
Wow, there were at least a hundred hands raised in the air, obviously everyone had a lot to talk about.
The host pointed to a doctor at the front of the venue: "Yes, this is the doctor from France. Please pass the microphone to the staff."
"Hello Dr. Chen, I have a question. Genetic testing is important for internal medicine. Everyone knows this. But for us surgeons, what is the role and significance of genetic testing? Can you give an example?"
p>
As soon as this question came up, many people nodded.
Compared with internal medicine, surgeons embody "doing" rather than "talking".
No matter how good your new technology is, unfortunately it cannot be used in surgical clinical practice and has no benefit for surgical diseases. So it is not appropriate for you to talk about genetic testing technology at the "World Congress of Surgery" today.
This has also resonated with many surgeons.
Chen Qi took the microphone but shook his head:
"My understanding is different from yours. We surgeons don't just complete an operation. For example, I gave an example of lung cancer in my speech. From our surgeon's point of view, I removed your tumor.
, it’s ok.
But from the patient's perspective, after the doctor removes the tumor, where did the tumor come from? Will it recur in the future? How should I prevent it next? How to improve the survival rate, this is all very critical, in layman's terms.
, we have to keep patients alive longer.
Therefore, whether you are a surgeon or a physician, it is not enough to cure your immediate pain. We should pay more attention to possible changes in the future so that we can prevent them as early as possible. This is one of the meanings of genetic testing.
p>
In addition, genetic testing plays a very important role in lung cancer. For example, we need to use genetic testing to confirm how lung cancer occurs and how cancer cells change. Then we can find out what are the driving genes of lung cancer cells?<
/p>
At this point, the bosses of pharmaceutical companies in the audience are paying attention. We have found a precise target for cancer cells. Let’s think about it in reverse, can we develop an effective gene-targeted drug to improve the patient’s survival?
Are the benefits getting higher and higher?
I call this a kind of "precision medicine". The development of this kind of biomarker will inevitably bring about changes in the diagnosis and treatment model of lung cancer, help doctors formulate precise treatment plans for lung cancer patients, and can also benefit more patients.<
/p>
I see the eyes of many pharmaceutical company bosses in the audience are starting to light up. I am just providing an idea on how to complete it. This requires the joint efforts of doctors and researchers. We all have a common goal.
It is to prolong the survival rate of patients."
As soon as Chen Qi finished speaking, the audience burst into even warmer applause.
Chen Qi has set the tone for the significance of genetic testing technology in surgical clinical practice, and even pointed out the direction of future development, which is to rely on genetic testing to invent a gene-targeted drug.
For top experts or top pharmaceutical giants, as long as you provide an idea, they can create unlimited possibilities.
Chen Qi is a reborn person, and of course he knows that targeted drugs will be widely used in clinical practice in later generations, so the direction he provides will definitely not be wrong.
For example, drugs that are often used clinically in later generations, such as gefitinib, osimertinib, etc., which target egfr gene-sensitive mutations, and crizotinib, ceritinib, etc., which target Oak gene fusions.
In addition, there are drugs targeting her-gene amplification, such as pertuzumab, trastuzumab, etc.
When biomarkers develop in the future, everyone will think of the future ideas that Chen Qi put forward presciently during his speech today.
Maybe he could even be called the "Father of Targeted Drugs".
I didn’t see that the bosses of the major pharmaceutical giants have already started to think deeply. They are probably excited and will definitely start researching it when they get back.
The happiest people are the bosses of the major genetic testing companies who came to the audience.
If Chen Qi's idea comes true, then the role of their genetic company will become more and more prominent in the future.
Genetic technology plays an outstanding role in clinical practice, which means that business will increase dramatically, and it will all be money. After all, the entry barriers to this industry are high, and they are the first batch of people to eat crabs.
Why do people open companies? Is it really for ideals? For love? For the health of all mankind?
Shit, it’s not just about money!
Chen Qi's speech today is undoubtedly a groundbreaking speech. At the same time, it was mentioned many times in the speech that the world's best genetic testing company, Japan's Sysmex, will enter the sight of the world's top surgeons.<
/p>
This made Yuto Takada smile so much that he couldn't close his mouth. These hundreds of thousands of dollars were a small thing to him, but this sponsorship was a big deal to his genetic company.
To be continued...